Selected Publications:
Shimazaki, K. Chan, A. M. Moniz, R. J. Wadehra, M. Nagy, A. Coulam, C. P. Mareninov, S. Lepin, E. M. Wu, A. M. Kelly, K. A. Braun, J. Gordon, L. K. Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model.
Fems Immunology and Medical Microbiology.
2009;
55( 2):
240-249.
Leyton, J. V. Olafsen, T. Sherman, M. A. Bauer, K. B. Aghajanian, P. Reiter, R. E. Wu, A. M. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.
Protein Engineering Design & Selection.
2009;
22( 3):
209-216.
Schipper, M. L. Iyer, G. Koh, A. L. Cheng, Z. Ebenstein, Y. Aharoni, A. Keren, S. Bentolila, L. A. Li, J. Q. Rao, J. H. Chen, X. Y. Banin, U. Wu, A. M. Sinclair, R. Weiss, S. Gambhir, S. S. Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice.
Small.
2009;
5( 1):
126-134.
Wu, A.M. Antibodies and antimatter: The resurgence of immunoPET.
J. Nucl.Med.
2009;
50:
2-5.
Leyton, J.V., Olafsen, T., Sherman, M.A., Bauer, K.B., Aghajanian, P., Reiter, R.E., and Wu, A.M. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen (PSCA)-expressing tumors.
Protein Engineering Design & Selection
2009;
22:
209-216.
Schipper, M.L., Iyer, G., Koh, A.L., Cheng, Z, Ebenstein, Y., Ahroni, A., Keren, S., Bentolilla, L., Li, J., Rao, J., Chen, X., Banin, U., Wu, A.M., Sinclair, R., Weiss, S., and Gambhir, S.S. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.
Small
2009;
5:
126-134.
Wu, A. M. Olafsen, T. Antibodies for molecular imaging of cancer.
Cancer Journal.
2008;
14( 3):
191-197.
Wei, L. H. Olafsen, T. Radu, C. Hildebrandt, I. J. Mccoy, M. R. Phelps, M. E. Meares, C. Wu, A. M. Czernin, J. Weber, W. A. Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging.
Journal of Nuclear Medicine.
2008;
49( 11):
1828-1835.
Leyton, J.V., Olafsen, T., Lepin, E.J., Hahm, S., Bauer, K., Reiter, R.E., and Wu, A.M. A humanized radioiodinated minibody as an imaging agent for the detection of prostate stem cell antigen (PSCA)-expressing tumors by microPET.
Clin. Canc. Res.
2008;
14:
7488-7496.
Wu, A.M. and Olafsen, T. Antibodies for Molecular Imaging of Cancer.
Cancer Journal
2008;
14:
191-197.
Shimazaki, K., Lepin, E.J., Wei, B., Nagy, A., Coulum, P., Mareninov, S., Fu, M., Wu, A.M., Marks, J.D., Braun, J., Gordon, L.K., and Wadehra, M. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Clin. Cancer Res.
2008;
14:
7367-7377.
Kenanova, V.E., Barat, B., Olafsen, T., Chatziioannou, A., Herschman, H.R., Braun, J., and Wu, A.M. Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging.
Eur. J. Nucl. Med. Molec. Imaging
2008;
36:
104-114.
Sirk, S., Olafsen, T., Barat, B., Bauer, K. B., McCabe, K.E., and Wu, A.M. Site-specific thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2.
Bioconjugate Chemistry
2008;
19:
2527-2534.
Venisnik, K. M. Olafsen, T. Gambhir, S. S. Wu, A. M. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.
Molecular Imaging and Biology.
2007;
9( 5):
267-277.
Barat, B. Wu, A. M. Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum.
Biomolecular Engineering.
2007;
24( 3):
283-291.
Loening, A. M. Wu, A. M. Gambhir, S. S. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects.
Nature Methods.
2007;
4( 8):
641-643.
Olafsen, T. Gu, Z. Sherman, M. A. Leyton, J. V. Witkosky, M. E. Shively, J. E. Raubitschek, A. A. Morrison, S. L. Wu, A. M. Reiter, R. E. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody.
Journal of Immunotherapy.
2007;
30( 4):
396-405.
Schipper, M.L., Cheng, Z., Lee, S.-W., Bentolila, L.A., Iyer, G., Rao, J., Chen, X., Wu, A.M., Weiss, S., and Gambhir, S.S. MicroPET-based biodistribution of quantum dots in living mice.
J. Nucl. Med.
2007;
48:
1511-1518.
Loening, A.M., Wu, A.M., and Gambhir, S.S. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects.
Nature Methods
2007;
4:
641-643.
Ferl, G. Z. Kenanova, V. Wu, A. M. DiStefano, J. J. A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments.
Molecular Cancer Therapeutics.
2006;
5( 6):
1550-1558.
Leyton, J. V. Olafsen, T. Sherman, M. A. Reiter, R. E. Wu, A. M. Anti-prostate stem cell antigen (PSCA) antibody fragments for pet imaging of prostate cancer.
Cancer Biotherapy and Radiopharmaceuticals.
2006;
21( 4):
391-391.
Venisnik, K. M. Olafsen, T. Loening, A. M. Iyer, M. Gambhir, S. S. Wu, A. M. Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors.
Protein Engineering Design & Selection.
2006;
19( 10):
453-460.
Loening, A. M. Fenn, T. D. Wu, A. M. Gambhir, S. S. Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output.
Protein Engineering Design & Selection.
2006;
19( 9):
391-400.
Li, L. Yazaki, P. J. Anderson, A. L. Crow, D. Colcher, D. Wu, A. M. Williams, L. E. Wong, J. Y. C. Raubitschek, A. Shively, J. E. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
Bioconjugate Chemistry.
2006;
17( 1):
68-76.
Olafsen, T. Kenanova, V. E. Leyton, J. V. Betting, D. Raubitschek, A. A. Timmerman, J. M. Reiter, R. E. Wu, A. M. Micropet evaluation of an I-124-labeled antibody fragment (scFv-Fc) in non-internalizing (CEA and CD20) versus internalizing (HER2 and PSCA) tumor antigen systems.
Cancer Biotherapy and Radiopharmaceuticals.
2006;
21( 4):
391-391.
Wong, J.Y.C., Chu, D.Z., Williams, L.E., Liu, A., Zhan, J., Yamauchi, D.M., Wilczynski, S., Wu, A.M., Yazaki, P.J., Shively, J.E., Leong, L., Raubitschek, A.A. A Phase I trial of 90Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Cancer Biother. Radiopharm.
2006;
21:
88-100.
Ferl, G.Z., Kenanova, V.E., Wu, A.M., and DiStefano III, J.J. A two-tiered physiologically-based model for dually labeled single chain Fv-Fc antibody fragments.
Mol. Cancer Therapeutics
2006;
5:
1550-1558.
Sui, G., Wang, J., Lee, C.C., Lu, W., Lee, S.P., Leyton, J.V., Wu, A.M., and Tseng, H.-R. Solution-phase surface modification in intact poly(dimethylsiloxane) microfluidic channels.
Anal. Chem.
2006;
78:
5543-5551.
Kenanova, V.E. and Wu, A.M. Tailoring antibodies for radionuclide delivery.
Exp. Opin. Drug Delivery
2006;
3:
53-70.
Olafsen, T Kenanova, VE Wu, AM Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment..
Nature protocols.
2006;
1(4):
2048-60.
Ferl, G. Z. Wu, A. M. Distefano, J. J. A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal fc receptor (FcRn).
Annals of Biomedical Engineering.
2005;
33( 11):
1640-1652.
Huang, S. C. Truong, D. Wu, H. M. Chatziioannou, A. F. Shao, W. Wu, A. M. Phelps, M. E. An Internet-based "kinetic imaging system" (KIS) for MicroPET.
Molecular Imaging and Biology.
2005;
7( 5):
330-341.
Wu, A. M. Senter, P. D. Arming antibodies: prospects and challenges for immunoconjugates.
Nature Biotechnology.
2005;
23( 9):
1137-1146.
Olafsen, T., Kenanova, V., Sundaresan, G., Anderson,A.-L., Crow, D., Yazaki, P.J., Li,L., Press, M.F., Gambhir, S.S., Williams, L.E., Wong, J.Y.C., Raubitschek, A.A., Shively, J.E., and Wu, A.M. Optimizing radiolabeled anti-p185HER2 antibody fragments for in vivo imaging.
Cancer Research
2005;
65:
5907-5916.
Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J., Sundaresan, G., Wu, A.M., Gambhir, S.S., and Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics.
Science
2005;
307:
538-544.
Yazaki, P. J. Sherman, M. A. Shively, J. E. Ikle, D. Williams, L. E. Wong, J. Y. C. Colcher, D. Wu, A. M. Raubitschek, A. A. Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Protein Engineering Design & Selection.
2004;
17( 5):
481-489.
Olafsen, T. Tan, G. J. Park, J. M. Crow, D. Li, L. Sundaresan, G. Gambhir, S. S. Shively, J. E. Raubitschek, A. A. Press, M. F. Wu, A. M. Tumor targeting, biodistribution and micro-PET imaging of engineered anti-HER2/neu antibody fragments in xenograft-bearing mice..
Journal of Nuclear Medicine.
2003;
44( 5):
363p-363p.
Jensen MC, Cooper LJ, Wu AM, Forman SJ, Raubitschek A Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy..
Cytotherapy. .
2003;
5(2):
131-8.
Sundaresan, G. Yazaki, P. J. Shively, J. E. Toyokuni, T. Nguyen, K. N. Finn, R. Larson, S. M. Raubitschek, A. A. Gambhir, S. S. Wu, A. M. I-124 radiolabeled genetically engineered anti-CEA antibody fragments for tumor imaging with microPET..
Journal of Nuclear Medicine.
2001;
42( 5):
153p-153p.
Abdel-Jalil, R. J. Walsh, J. C. Stone, J. L. Shively, J. E. Satyamurthy, N. Barrio, J. R. Phelps, M. E. Wu, A. M. Gambhir, S. S. Toyokuni, T. Synthesis of 4-[(4-(18)Ffluorobenzylidene) aminooxy]butyl vinyl sulfone as an amine- and thiol-reactive F-18-labeling agent..
Journal of Nuclear Medicine.
2001;
42( 5):
256p-256p.
Leyton, J. V. Olafsen, T. Lepin, E. J. Hahm, S. Bauer, K. B. Reiter, R. E. Wu, A. M. Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors.
Clinical Cancer Research.
2008;
14( 22):
7488-7496.
Loening, AM Wu, AM Gambhir, SS Red-shifted Renilla reniformis luciferase variants for imaging in living subjects..
Nature methods.
2007;
4(8):
641-3.
Barat, B Wu, AM Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum..
Biomolec. Eng..
2007;
ePub:
.
Kenanova, V. Olafsen, T. Williams, L. E. Ruel, N. H. Longmate, J. Yazaki, P. J. Shively, J. E. Colcher, D. Raubitschek, A. A. Wu, A. M. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: Optimal pharmacokinetics for therapy.
Cancer Research.
2007;
67( 2):
718-726.
Sui, G. D. Wang, J. Y. Lee, C. C. Lu, W. X. Lee, S. P. Leyton, J. V. Wu, A. M. Tseng, H. R. Solution-phase surface modification in intact poly(dimethylsiloxane) microfluidic channels.
Analytical Chemistry.
2006;
78( 15):
5543-5551.
Olafsen, T. Kenanova, V. E. Sundaresan, G. Anderson, A. L. Crow, D. Yazaki, P. J. Li, L. Press, M. F. Williams, L. E. Wong, J. Y. C. Raubitschek, A. A. Shively, J. E. Wu, A. M. Optimizing radiolabeled engineered anti-p185(HER2) antibody fragments for in vivo imaging.
Cancer Research.
2005;
65( 13):
5907-5916.
Michalet, X. Pinaud, F. F. Bentolila, L. A. Tsay, J. M. Doose, S. Li, J. J. Sundaresan, G. Wu, A. M. Gambhir, S. S. Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics.
Science.
2005;
307( 5709):
538-544.
Kenanova, V. Olafsen, T. Crow, D. M. Sundaresan, G. Subbarayan, M. Carter, N. H. Ikle, D. N. Yazaki, P. J. Chatziioannou, A. F. Gambhir, S. S. Williams, L. E. Shively, J. E. Colcher, D. Raubitschek, A. A. Wu, A. M. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Cancer Research.
2005;
65( 2):
622-631.
Wong, J. Y. C. Chu, D. Z. Williams, L. E. Yamauchi, D. M. Ikle, D. N. Kwok, C. S. Liu, A. Wilczynski, S. Colcher, D. Yazaki, P. J. Shively, J. E. Wu, A. M. Raubitschek, A. A. Pilot trial evaluating an I-123-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Clinical Cancer Research.
2004;
10( 15):
5014-5021.
Olafsen T, Tan GJ, Cheung CW, Yazaki PJ, Park JM, Shively JE, Williams LE, Raubitschek AA, Press MF, Wu AM Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting..
Protein engineering, design & selection : PEDS. .
2004;
17(4):
315-23.
Olafsen T, Cheung CW, Yazaki PJ, Li L, Sundaresan G, Gambhir SS, Sherman MA, Williams LE, Shively JE, Raubitschek AA, Wu AM Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications..
Protein engineering, design & selection : PEDS. .
2004;
17(1):
21-7.
Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM, Raubitschek AA, Williams LE, Chatziioannou AF, Gambhir SS, Wu AM 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice..
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. .
2003;
44(12):
1962-9.
Ray, P. Wu, A. M. Gambhir, S. S. Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice.
Cancer Research.
2003;
63( 6):
1160-1165.
Carmichael JA, Power BE, Garrett TP, Yazaki PJ, Shively JE, Raubischek AA, Wu AM, Hudson PJ The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
J Mol Biol.
2003;
326(2):
341-51.
Wu, A. M. Yazaki, P. J. Tsai, S. W. Nguyen, K. Anderson, A. L. McCarthy, D. W. Welch, M. J. Shively, J. E. Williams, L. E. Raubitschek, A. A. Wong, J. Y. C. Toyokuni, T. Phelps, M. E. Gambhir, S. S. High-resolution microPET imaging of carcino-embryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
Proceedings of the National Academy of Sciences of the United States of America.
2000;
97( 15):
8495-8500.
|